- Investing Ideas
- /
- Austrian Pharmaceuticals & Biotech Potentially Undervalued Companies
Austrian Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Apr 21, 2024
Companies with a Value score of at least 3, ordered by Value score
30 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MRCK | €145.90 | -4.0% | -11.8% | €63.5b | €181.88 | PE22.5x | E10.0% | 1.5% | ||
BIIB | US$178.80 | -4.5% | -32.9% | US$28.3b | US$267.52 | PE24.3x | E18.2% | n/a | ||
GILD | US$62.24 | -2.9% | -21.3% | US$83.2b | US$79.48 | PE14.7x | E10.0% | 4.6% | ||
IQVH | US$215.20 | -2.2% | 17.7% | US$41.5b | US$259.82 | PE30.6x | E12.7% | 0% | ||
SANO | €85.21 | -2.2% | -17.4% | €108.5b | €105.42 | PE20.1x | E13.8% | 4.3% | ||
LUNB | kr.4.38 | -2.3% | -8.0% | kr.31.5b | kr.5.19 | PE14.2x | E9.9% | 2.1% | ||
VTRS | US$10.49 | -1.6% | 18.9% | US$13.4b | US$11.56 | PE244.2x | E16.0% | 4.3% | ||
BMYS | US$45.31 | -1.8% | -29.0% | US$99.2b | US$52.15 | PE12.4x | E8.3% | 4.9% | ||
IPN | €105.90 | -3.5% | -0.2% | €9.0b | €121.75 | PE14.5x | E6.0% | 1.1% | ||
LUNA | kr.3.74 | -1.4% | -17.9% | kr.31.5b | kr.4.43 | PE14.2x | E9.9% | 2.1% | ||
TLRY | US$1.64 | -7.0% | -24.0% | US$1.3b | US$2.25 | PS1.8x | E86.1% | n/a | ||
REGN | US$841.60 | -1.3% | 15.5% | US$96.4b | US$971.91 | PE24.4x | E10.9% | n/a | ||
JNJ | US$137.32 | -1.9% | -7.3% | US$356.4b | US$160.17 | PE18.6x | E5.1% | 3.4% | ||
EVT | €13.28 | -4.0% | -25.3% | €2.4b | €25.44 | PS2.9x | E57.9% | n/a | ||
BAVA | kr.19.74 | -4.2% | -21.9% | kr.11.5b | kr.35.47 | PE7.8x | E-16.2% | n/a | ||
MRNA | US$96.03 | -2.9% | -23.3% | US$38.8b | US$127.17 | PS5.7x | E56.0% | n/a | ||
GXI | €98.90 | -0.1% | 9.4% | €3.4b | €132.43 | PE29.2x | E20.8% | 1.3% | ||
ALM | €8.22 | 0.4% | -11.0% | €1.7b | €11.25 | PS1.9x | E47.0% | 2.3% | ||
QGE2 | US$37.44 | -0.2% | -11.3% | US$8.9b | US$47.49 | PE25.9x | E11.3% | n/a | ||
TEVA | US$12.30 | -0.8% | 61.8% | US$14.6b | US$15.05 | PB1.9x | E32.1% | 0% | ||
AMGN | US$249.00 | -1.1% | 12.0% | US$144.2b | US$278.01 | PE21.5x | E8.9% | 3.3% | ||
GMAB | kr.269.80 | -2.6% | -28.2% | kr.130.4b | kr.327.36 | PE30x | E21.7% | n/a | ||
BMRN | US$85.34 | -2.0% | -3.6% | US$16.8b | US$105.98 | PE100.3x | E30.9% | n/a | ||
ROVI | €79.45 | -3.1% | 93.0% | €4.1b | €79.22 | PE24.2x | E15.2% | 1.4% |